| 标题 |
 Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
Nole
cdercder
馨馨的科科
DOC_XIONG
xing_xing
aaaa
奔跑
zack6119
Viper
学术文献互助
OK
sagitar
初景
共产主义战士
GingerF
Dean
善良紫南
Freud
十有五
皖公网安备34019202002308
